News
Stay up-to-date on current women’s health news, articles and videos from Speaking of Women's Health, as well as developments from other women’s health news outlets.
FDA Approves Weekly Contraceptive Patch Twirla
The FDA approved Twirla®, a weekly contraceptive patch containing 30 mcg levonorgestrel and 120 mcg ethinyl estradiol, for women of reproductive age with a BMI less than 30 kg/m2 and for whom a…
WHO declares China virus outbreak an international emergency
The World Health Organization declared on Thursday that the coronavirus epidemic in China now constitutes a public health emergency of international concern.
FDA Warning: Weight Loss Drug Belviq May Increase Cancer Risk
A recent clinical trial assessing the safety of weight-loss drugs Belviq and Belviq XR (lorcaserin) has led to the FDA issuing a public alert, warning that the drug may contribute to cancer risk.“At…
Menopause Specialist Makes Virtual Visits a Hallmark of Her Evolving Practice
High physician/patient convenience and satisfaction cited
New Osteoporosis Patch Study: Recruiting Postmenopausal Women
Cleveland Clinic is recruiting postmenopausal women for a new Tymlos Patch study. The trial compares Abaloparatide/Tymlos(R) injection vs Tymlos(R) patch.
Cleveland Clinic Unveils Top 10 Medical Innovations for 2020
A panel of top doctors and researchers presents the medical advancements with the power to transform healthcare in the next year
FDA Approves New Drug for Cystic Fibrosis
A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration.Trikafta (elexacaftor/ivacaftor/tezacaftor) is the first triple combination therapy…
Cost-Comparison Analysis of APEX M™ Pelvic Floor Therapy for the Treatment and Management of Female Urinary Incontinence
The primary objective of this study was to assess the efficacy of APEX M™ pelvic floor therapy, a pelvic stimulating device, for women with urinary incontinence (UI) from April 1, 2014 to January 31,…
FDA approves Reyvow, a new treatment for patients with migraine
The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual…
FDA: More high blood pressure medications recalled due to cancer risk
Another drug has been added to a recall for medication used to treat high blood pressure. Torrent Pharmaceuticals Limited is recalling several batches of Losartan Potassium tablets, the FDA…